Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.

Objectives: To study neonatal outcomes following buprenorphine/naloxone and methadone exposure during pregnancy.

Methods: This study is a retrospective review of clinical and demographic information of 58 infants whose mothers were treated with buprenorphine/naloxone and 92 infants whose mothers were treated with methadone for opioid dependence during pregnancy.

Results: Gestational age, birth weight, prematurity, admission to neonatal intensive care unit, and length of stay were similar between both groups of infants.